Evidence map›Paper›PMID 29250050›Full record

ArticleFrontiers in microbiology2017

Anilinopyrimidine Resistance in

Andreas Mosbach, Dominique Edel, Andrew D Farmer, Stephanie Widdison, Thierry Barchietto, Robert A Dietrich, Andy Corran, Gabriel Scalliet

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
7.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Multiple and multidrug resistance inFrontiers in plant science · 2023
    Article
  16. A Melanin-Deficient Isolate ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  17. Detection ofMicroorganisms · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Andreas MosbachSyngenta Crop Protection AG, Stein, Switzerland.
Dominique EdelSyngenta Crop Protection AG, Stein, Switzerland.
Andrew D FarmerNational Center for Genome Resources, Santa Fe, NM, United States.
Stephanie WiddisonSyngenta Jealott's Hill International Research Centre, Bracknell, United Kingdom.
Thierry BarchiettoBIOtransfer, Montreuil, France.
Robert A DietrichSyngenta Biotechnology Inc., Research Triangle Park, NC, United States.
Andy CorranSyngenta Jealott's Hill International Research Centre, Bracknell, United Kingdom.
Gabriel ScallietSyngenta Crop Protection AG, Stein, Switzerland.
Syngenta (Switzerland) · CHSyngenta (United Kingdom) · GBNational Center for Genome Resources · USSyngenta (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crop protection anilinopyrimidine (AP) fungicides were introduced more than 20 years ago for the control of a range of diseases caused by ascomycete plant pathogens, and in particular for the control of gray mold caused by

Indexed as

ABC transporteranilinopyrimidineBotrytis cinereafungicide resistancegray moldmitochondriaNADH kinase

Identifiers

PMID29250050
PMCPMC5714876
OpenAlexW2768397683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.